The I+i en Farmacia Hospitalaria brand is a renowned provider of innovative pharmaceutical services. Their services include experimental imaging, pharmacokinetics, and biomarkers for molecular imaging. The brand is supported by the Unidad de Investigación e Innovación (UII-FH), which is an integral part of the Pharmacy Service at the Santiago University Clinical Hospital.

The UII-FH is accredited with ISO 9001:2015 and consists of experienced researchers and medical professionals with cross-disciplinary expertise. The brand's research areas cover a wide range of topics, such as personalized drug development (FAR-GALenia), pharmacokinetics for personalized medicine (FAR-PRO-PKgen), and independent clinical research (FAR-ICI). These research initiatives are coordinated by the Santiago de Compostela Health Research Institute (IDIS), which is a nationally recognized institution for healthcare innovation and knowledge transfer.

The UII-FH's expertise extends to various areas, including the individualized development of medications, pharmacokinetic techniques, and pharmacogenetics. Their research aims to understand the variability in response to drugs used in clinical practice. Additionally, they conduct independent clinical trials to evaluate the impact of formulations and interventions developed in their research areas.

With the support and funding from the Axencia Galega de Innovación de la Xunta de Galicia (ACIS, GAIN), the UII-FH has been recognized as a group with significant growth potential in the field of biosanitary research. Overall, I+i en Farmacia Hospitalaria is a leading brand that combines expertise, research, and innovation to provide exceptional pharmaceutical services and contribute to the advancement of healthcare